SCHEMBL6975784

SCHEMBL6975784

CCOC(=O)C(CN)c1ccc2c(c1)OCO2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.51
CYP3A4 P08684 2/20 0.51
NPC1 O15118 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HTT P42858 1/20 0.51
EDNRA P25101 1/20 0.49
MAPK9 P45984 1/20 0.49
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
KMT2A Q03164 3/20 0.47
OGA O60502 2/20 0.46
HPGD P15428 2/20 0.46
MAPT P10636 2/20 0.45
TSHR P16473 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MEN1 O00255 2/20 0.45
PRKCI P41743 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21656188 0.88 EDNRA (0.62) RAB9ACYP3A4NPC1CYP1A2CYP2D6
SCHEMBL7359562 0.84 EDNRA (0.54) RAB9ACYP3A4NPC1CYP1A2CYP2D6
SCHEMBL7502509 0.83 RAB9A (0.53) RAB9ACYP3A4NPC1CYP1A2CYP2D6
SCHEMBL6138702 0.83 RAB9A (0.56) RAB9ACYP3A4NPC1CYP1A2CYP2D6
SCHEMBL8789026 0.82 RAB9A (0.55) RAB9ACYP3A4NPC1CYP1A2CYP2D6
SCHEMBL12053329 0.82 CYP3A4 (0.55) RAB9ACYP3A4NPC1CYP1A2CYP2D6
SCHEMBL7269510 0.81 MAPK9 (0.66) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6985620 0.81 MAPK9 (0.66) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7332440 0.81 CYP3A4 (0.53) RAB9ACYP3A4NPC1CYP1A2CYP2D6
SCHEMBL24580937 0.80 CYP3A4 (0.52) RAB9ACYP3A4NPC1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed
WO-2018189011-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-10-18 WO disclosed
EP-0630366-B1 SUBSTITUTED HETEROCYCLIC DERIVATIVES USEFUL AS PLATELET AGGREGATION INHIBITORS SEARLE & CO (US) 2003-01-02 EP disclosed
EP-0539343-B1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors MONSANTO CO (US) 2000-07-26 EP disclosed
US-5378727-A ADMINISTERING TO MAMMALS G. D. SEARLE & CO. (US) 1995-01-03 US disclosed
US-5254573-A Substituted heterocyclic derivatives useful as platelet aggregation inhibitors MONSANTO COMPANY (US) 1993-10-19 US disclosed